DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Kato K, Sun J, Shah MA. et al.
Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study.
Ann Oncol 2020;
31 (Suppl. 04) S1142-S1215
DOI: 10.1016/annonc/annonc325. Abstract LBA8_PR
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.